Proteocyte AI

25/08/2025

Worried about a spot in your mouth that won’t heal?

You’re not alone — and you’re not without options.

STRATICYTE™ works with your doctor to provide clarity - using advanced science, helping you:

🔹 Understand your personal risk
🔹 Make informed decisions
🔹 Act quickly— with confidence

Since 2011, Proteocyte AI has helped patients and clinicians to stay ahead of oral cancer.

💡 Learn how STRATICYTE™ fits into your care journey: https://proteocyte.com/straticyte/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

20/08/2025

You and your patients deserve care backed by the highest standards.

At Proteocyte AI, everything we do is built on a foundation of quality.

Our commitment to excellence means you and your patients can trust the results that support your care.

Use STRATICYTE™ to go beyond traditional pathology — analyzing patient biopsies for key biomarkers to look deeper, see farther.

Every lesion and patient is different: STRATICYTE™ provides crucial insight, supporting informed, confident decision-making to shape and guide treatment plans.

🔬 Trusted science. ✅ Rigorous standards. 💙 Personalized care.

Learn more about STRATICYTE™: https://proteocyte.com/straticyte/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

18/08/2025

"STRATICYTE might be the Holy Grail in management of OPMD that we have been waiting for, for years" – Dr. Eric Dierks, MD, DMD, FACS, FACD, FRCS(Ed), Founding Partner Head & Neck Surgical Associates Portland, Oregon

✅ Accurate
✅ Objective
✅ Personalized
✅ Clinically Validated

STRATICYTE™ is a proteomic test that predicts the 5-year risk of your oral precancer (OPMD) lesion becoming OSCC (oral cancer). It includes measuring S100A7 biomarker levels in your biopsy. S100A7 is associated with malignancy and poor outcomes in many other cancers.

Early diagnosis, prediction and treatment are critical to help ensure best outcomes. STRATICYTE’s 5-year risk window can offer clinicians and patients peace of mind and a clear path forward – helping patients live better, longer.

Go beyond standard with STRATICYTE. To learn more visit: www.proteocyte.com.

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

13/08/2025

When it comes to oral cancer, early detection, early prediction and early care management isn’t just important — it’s life-saving.

Early diagnosis, prediction and treatment are crucial to ensure best outcomes. When caught in late stages, oral cancer can require aggressive surgery, resulting in significant lifestyle changes, and reduced survival odds.

💡 That’s where STRATICYTE™ comes in.

Our advanced, AI-driven cellular analysis uses your existing biopsy sample to predict the 5-year risk of precancerous lesion(s) progressing to oral cancer.

✅ Simple
✅ Precise
✅ Effective
✅Clinically validated

STRATICYTE provides informed decision- making opportunities to you and your doctor— supporting those at higher risk while reassuring those at low or no risk.

Learn more and talk to your doctor about STRATICYTE. Visit https://proteocyte.com/straticyte/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

11/08/2025

Oral cancer can be a silent killer however if caught early it can be managed effectively.

Be aware of the signs:

➡️ Sores that don’t heal within 2 weeks
➡️ White, red, or speckled patches in your mouth
➡️ Lumps or ulcers on the lips or inside your mouth
➡️ Persistent sore throat or trouble swallowing
➡️ Bleeding in your mouth
➡️ Lumps in your neck

If you Spot it, Test it!

STRATICYTE™ supports doctors and clinicians in identifying the 5-year risk of your lesion progressing to cancer — all while using your existing biopsy.

Your 5-year personalized STRATICYTE risk score offers peace of mind and a clear path forward.

Learn more: https://proteocyte.com/straticyte/patients/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

29/07/2025

How can STRATICYTE™ help avoid trial and error in managing precancerous oral lesions?

Using AI-driven digital technology, the S100A7 biomarker assay is used to calculate a personalized risk score (RS), providing guidance and peace of mind. Your patient’s RS is compared with a large cohort of patients with known clinical outcomes and at least five years of follow up.

Consider STRATICYTE and personalize the management of your oral precancer (OPMD) patients today.

Learn more at https://proteocyte.com/straticyte/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

22/07/2025

Founded in 2011, Proteocyte AI started developing a platform of solutions to predict cancer risk, including Straticyte for accurate prediction of Oral Cancer Risk.

The limitations with the current standard of care have led to a widely recognized urgent need for more effective prognostic biomarkers for oral potentially malignant lesions.

Proteocyte’s mission is to provide healthcare professionals with more insightful, objective, and quantifiable data, to support effective patient management and improve patient outcomes.

Proteocyte’s STRATICYTE™ test predicts the progression of precancerous oral lesions (OPMD) to invasive cancer (OSCC), across a 5-year span. STRATICYTE’s ability to ‘look deeper and see farther’ enables healthcare professionals to customize patient management and treatment, offering peace of mind and a clear path forward.

Learn more at https://proteocyte.com/straticyte/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

18/07/2025

STRATICYTE™ is a test that predicts the progression of pre-malignant lesions to invasive oral cancer. It enables healthcare professionals to customize patient management plans to improve outcomes for patients at elevated risk for developing oral cancer, while reassuring those patients who have minimal to no risk of progression.

It is a predictive test that can objectively distinguish oral lesions at elevated risk of becoming cancerous from those with little to no risk.

Straticyte was developed utilizing retrospective clinical data (168 dysplasia cases and 427 cancer cases). Proteocyte is committed to enriching its dataset with annotated study cohorts and has several ongoing studies with with major oral pathology centers.

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

17/07/2025

"We've trained our machine learning process to figure out the expression of S100A7 within the nucleus of the cells, what over-expression looks like comparative to the data that we have and it also takes into account nuclear size." - Dr. Paras Patel, DDS Board-certified Oral and Maxillofacial Pathologist, Director of Oral Maxillofacial Pathology at ProPath; Owner and co-founder of the Center for Oral Pathology, Dallas, TX; Principal US Lab Director at Proteocyte AI

In our latest Care to Know webinar, Drs. Laudenbach, Patel, and co-facilitator Dr. Jaisrie Thoppay (President-elect, American Academy of Oral Medicine) examined the science and data behind STRATICYTETM, sharing examples of in-practice use in supporting decision-making and enhancing patient compliance - including feedback from patients.

Simply Order the Test, Proteocyte does the rest! For more information on STRATICYTE™ or to access the on-line Test Request Form visit www.proteocyte.com

Access the recorded video here: https://drive.google.com/file/d/1WV4aoCgFeG-Ep4Fv3jwEdukKhY-iACJa/view?usp=sharing

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

15/07/2025

Are you at risk of developing oral cancer?

Ask your healthcare provider about STRATICYTE™. STRATICYTE is a biomarker test that provides you with a personalized risk score to help you and your physician effectively plan ahead for peace of mind. Follow these three tips to assess your risk of oral cancer for the next 5 years.

➡️ Spot it. Test it.

The spot in your mouth could be cancer or it could become cancer. The only way to know for sure is to have it tested. Standard tests examine your biopsy for changes to determine if there is cancer or precancer but can’t accurately predict if it may turn into cancer.

➡️ See 5 years ahead.

STRATICYTE builds on routine pathology findings (what is there) using AI, to give you and your physician your 5-year personalized risk score (what may come). STRATICYTE’s 5-year view can help you predict what may come, and plan ways to protect your health to live better, longer.

➡️ No extra biopsies.

STRATICYTE uses the biopsy you already gave. No extra appointments or needles to worry about.

To learn more about Proteocyte AI and the STRATICYTE™ test visit www.proteocyte.com.

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

14/07/2025

Oral precancer lesions can appear as simple red or white spots in the mouth — often without any symptoms. Identifying whether these spots are precancerous requires a biopsy and expert analysis.

That’s where STRATICYTE™ by Proteocyte AI can help. STRATICYTE builds on routine pathology findings using AI to examine key biomarkers within oral lesions, providing detailed insight into the unique biology of a lesion. The Straticyte 5-year personalized risk score can help support more confident, informed decisions for effective clinical management planning.
Oral cancer is serious — it can require major surgery, drastically affect quality of life, and be life-threatening if detected too late. Early detection and prediction are crucial.

👉 Watch our full video to learn how Straticyte is transforming oral cancer prediction to support effective patient management and to help improve patient outcomes: https://www.youtube.com/watch?v=m7boEYIsQpk

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

A test that assesses the risk of trasformation of an oral pre-malignant lesion to invasive oral cancer.

09/07/2025

Over 50,000 North Americans will be diagnosed with oral cancer this year alone.

10,000 of those cases (1 in 5) will be fatal. Early detection and prediction is critical for the best outcomes and best survival rates.

Proteocyte AI’s innovative STRATICYTE™ test, is an extensively validated, tissue-based prognostic test that applies AI-driven software to accurately and objectively predict the progression of pre-malignant lesions to invasive oral cancer and provides patients and physicians with an individualized 5-year risk score. Straticyte can support healthcare professionals with patient management plans to improve outcomes for patients at elevated risk for developing oral cancer, while reassuring those patients who have minimal to no risk of progression.

Learn more about STRATICYTE™ by visiting https://proteocyte.com/straticyte/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , , , , , , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association